| Title |
Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials
|
|---|---|
| Published in |
Intensive Care Medicine, December 2011
|
| DOI | 10.1007/s00134-011-2435-6 |
| Pubmed ID | |
| Authors |
Catherine L. Tacon, John McCaffrey, Anthony Delaney |
| Abstract |
Dobutamine is recommended for patients with severe heart failure; however uncertainty exists as to its effect on mortality. This study aims to critically review the literature to evaluate whether dobutamine, compared with placebo or standard care, is associated with lower mortality and a range of secondary outcomes, in patients with severe heart failure. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 67% |
| Members of the public | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 1% |
| Norway | 1 | <1% |
| South Africa | 1 | <1% |
| Finland | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 155 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 30 | 18% |
| Student > Postgraduate | 21 | 13% |
| Researcher | 16 | 10% |
| Student > Bachelor | 15 | 9% |
| Student > Ph. D. Student | 15 | 9% |
| Other | 38 | 23% |
| Unknown | 28 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 109 | 67% |
| Nursing and Health Professions | 5 | 3% |
| Engineering | 3 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 1% |
| Agricultural and Biological Sciences | 2 | 1% |
| Other | 7 | 4% |
| Unknown | 35 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2024.
All research outputs
#3,227,738
of 26,017,215 outputs
Outputs from Intensive Care Medicine
#2,114
of 5,570 outputs
Outputs of similar age
#23,659
of 251,836 outputs
Outputs of similar age from Intensive Care Medicine
#2
of 30 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,570 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.4. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,836 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.